Skip to main content
Year archive

Abliva — 2013 filings

All 35 regulatory filings released by Abliva (ABLI) in 2013, sourced directly from the official regulator.

35 Filings
2013 Period
2013 filings (35)
Filing Released Lang
Riktad nyemission i NeuroVive på 35 MSEK genomförd och mer information om kommande företrädesemission på 75,8 MSEK
Capital/Financing Update
2013-12-18 Swedish
NeuroVive—SEK 35 m private placement complete, more information on forthcoming SEK 75.8 m rights issue
Share Issue/Capital Change
2013-12-18 English
Report from Extraordinary General Meeting
AGM Information
2013-12-13 English
Kommuniké från extra bolagsstämma
AGM Information
2013-12-13 Swedish
Correction: NeuroVive proposes resolution on private placement and rights issue totaling approximately SEK 111 m
Report Publication Announcement
2013-11-21 English
Rättelse: NeuroVive föreslår beslut om riktad nyemission och företrädesemission om totalt cirka 111 MSEK
Capital/Financing Update
2013-11-21 Swedish
Interim / Quarterly Report 2013
Interim / Quarterly Report 9M 2013
2013-11-20 English
NeuroVive proposes resolution on private placement and rights issue totaling approximately SEK 111 m
Capital/Financing Update
2013-11-20 English
Interim / Quarterly Report 2013
Interim / Quarterly Report 9M 2013
2013-11-20 Swedish
Kallelse till extra bolagsstämma i NeuroVive Pharmaceutical AB (publ)
AGM Information
2013-11-20 Swedish
Årsstämma 2014 och information om utsedda ledamöter till valberedningen
AGM Information
2013-11-08 Swedish
Catharina Johansson utsedd till ny CFO, tillträder den 1 december
Board/Management Information
2013-10-09 Swedish
Catharina Johansson appointed new CFO, effective 1 December
Board/Management Information
2013-10-09 English
800 patienter inkluderade i europeisk fas III-studie med CicloMulsion®
Regulatory Filings
2013-09-09 Swedish
Fortsatta framsteg för NeuroVives satsning i Kina
Regulatory Filings
2013-09-05 Swedish
Major Shareholding Notification 2013
Major Shareholding Notification
2013-08-30 English
Major Shareholding Notification 2013
Major Shareholding Notification
2013-08-29 English
Major Shareholding Notification 2013
Major Shareholding Notification
2013-08-28 English
Major Shareholding Notification 2013
Major Shareholding Notification
2013-08-27 English
Interim / Quarterly Report 2013
Interim / Quarterly Report H1 2013
2013-08-23 Swedish
Interim / Quarterly Report 2013
Interim / Quarterly Report H1 2013
2013-08-23 English
Major Shareholding Notification 2013
Major Shareholding Notification
2013-08-14 English
NeuroVive tecknar samarbetsavtal med Isomerase Therapeutics och erhåller den första milestone-ersättningen från Sihuan
Regulatory Filings
2013-06-12 Swedish
NeuroVive signs collaboration agreement with Isomerase Therapeutics and receives the first milestone payment from Sihuan
Regulatory Filings
2013-06-12 English
First patient recruited to clinical phase II study for treatment of traumatic brain injury
Regulatory Filings
2013-06-05 English
Första patienten rekryterad till klinisk fas II-studie för behandling av traumatisk hjärnskada
Regulatory Filings
2013-06-05 Swedish
Inleder rekrytering av ny CFO med tillträde i höst
Board/Management Information
2013-05-31 Swedish
NeuroVive: European phase III study approaches its final stage
Regulatory Filings
2013-05-29 English
NeuroVive: Europeisk fas III-studie av CicloMulsion närmar sig slutfasen
Regulatory Filings
2013-05-29 Swedish
Interim / Quarterly Report 2013
Interim / Quarterly Report Q1 2013
2013-05-24 English
Interim / Quarterly Report 2013
Interim / Quarterly Report Q1 2013
2013-05-24 Swedish
NeuroVive inleder IR-satsning med Laika Consulting
Regulatory Filings
2013-05-08 Swedish
NeuroVive starts Investor Relations Partnership with Laika Consulting
Regulatory Filings
2013-05-08 English
Klargörande avseende framtida kapitalbehov
Capital/Financing Update
2013-04-17 Swedish
Major Shareholding Notification 2013
Major Shareholding Notification
2013-04-10 English